These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10394721)

  • 21. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins.
    Hefferon KL
    Virology; 2012 Nov; 433(1):1-6. PubMed ID: 22979981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
    Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
    J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular vaccine prepared by fusion of XCL1 to the multi-epitope protein of foot-and-mouth disease virus enhances the specific humoural immune response in cattle.
    Li K; Bao H; Wei G; Li D; Chen Y; Fu Y; Cao Y; Li P; Sun P; Bai X; Ma X; Zhang J; Lu Z; Liu Z
    Appl Microbiol Biotechnol; 2017 Nov; 101(21):7889-7900. PubMed ID: 28929328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
    Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
    Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technology evaluation: HspE7, StressGen Biotechnologies Corp.
    Hunt S
    Curr Opin Mol Ther; 2001 Aug; 3(4):413-7. PubMed ID: 11525566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances of cowpea mosaic virus-based particle technology.
    Montague NP; Thuenemann EC; Saxena P; Saunders K; Lenzi P; Lomonossoff GP
    Hum Vaccin; 2011 Mar; 7(3):383-90. PubMed ID: 21368585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
    Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression & immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus.
    Yasawardene SG; Lomonossoff GP; Ramasamy R
    Indian J Med Res; 2003 Sep; 118():115-24. PubMed ID: 14700344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella.
    Whittle BL; Lee E; Weir RC; Verma NK
    J Med Microbiol; 1997 Feb; 46(2):129-38. PubMed ID: 9060872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The quality of papers in Viral Immunology continues to rise.
    Woodland DL
    Viral Immunol; 2010 Apr; 23(2):125-6. PubMed ID: 20373992
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant fusion peptides containing single or multiple repeats of a ubiquitous T-helper epitope are highly immunogenic.
    Astori M; Kraehenbuhl JP
    Mol Immunol; 1996 Sep; 33(13):1017-24. PubMed ID: 9010240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simian immunodeficiency virus DNA vaccine trial in macaques.
    Robinson HL; Lu S; Mustafa F; Johnson E; Santoro JC; Arthos J; Winsink J; Mullins JI; Montefiori D; Yasutomi Y
    Ann N Y Acad Sci; 1995 Nov; 772():209-11. PubMed ID: 8546394
    [No Abstract]   [Full Text] [Related]  

  • 34. Cowpea mosaic virus-based systems for the production of antigens and antibodies in plants.
    Liu L; Cañizares MC; Monger W; Perrin Y; Tsakiris E; Porta C; Shariat N; Nicholson L; Lomonossoff GP
    Vaccine; 2005 Mar; 23(15):1788-92. PubMed ID: 15734042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.
    Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.
    Kit M; Kit S; Little SP; Di Marchi RD; Gale C
    Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials.
    Chatterji A; Burns LL; Taylor SS; Lomonossoff GP; Johnson JE; Lin T; Porta C
    Intervirology; 2002; 45(4-6):362-70. PubMed ID: 12602357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
    Bruening G; Buzayan JM; Ferreiro C; Lim W
    Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
    Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
    Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.